ULIHF ファイナンス： The United Laboratories International Holdings Limited AI分析



財務状況

ULIHF 財務

The United Laboratories International Holdings Limited

$1.24

終値： Jun 18, 16:00:00 GMT-4

$1.24

アフターマーケット：Jun 18, 20:00:00 GMT-4

概要予測収入配当財務状況

主要データ

前終値

$1.24

始値

$1.3

当日レンジ

$1.24 - $1.3

52週レンジ

$1.17 - $2.27

取引高

1.0K

平均取引高

298

配当利回り

1株当たり利益(TTM)

0.16

時価総額

$2.4B

UNITED LABORATORIES INTL HLDGS とは何ですか？

The United Laboratories International Holdings Ltd. is an investment company, which engages in manufacturing and selling medicine products. The company employs 18,000 full-time employees The company went IPO on 2007-06-15. The firm operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.

特徴

Markets

News

利用規約プライバシーポリシー

Breakdown	TTM	12/31/2025	06/30/2025	12/31/2024	06/30/2024	12/31/2023
収入	13,210	5,691	7,518	6,583	7,175	6,833
収益成長率（YoY）	-4%	-14%	5%	-4%	4%	11%
収益のコスト	7,696	4,101	3,594	3,845	3,831	3,711
売上総利益	5,514	1,590	3,923	2,738	3,344	3,121
販売、一般および管理	2,322	1,189	1,133	1,242	1,099	1,019
研究開発	921	422	498	443	446	418
運営費用	3,093	1,483	1,609	1,525	1,517	1,385
その他の非営業収入（費用）	--	--	--	--	--	--
税引前利益	2,527	108	2,419	1,387	1,901	1,731
所得税費	446	-79	526	220	410	315
純利益	2,085	191	1,894	1,168	1,491	1,416
純利益成長率	-22%	-84%	27%	-18%	16%	49%
流通済み株式数（希薄化後）	1,953.28	1,953.28	1,816.93	1,816.6	1,817.02	1,817.02
株式変動（前年比）	8%	8%	0%	0%	0%	0%
EPS（希薄化）	1.06	0.09	1.04	0.64	0.82	0.77
EPS成長率	-28%	-85%	27%	-18%	16%	49%
フリーキャッシュフロー	855	585	270	301	1,027	301
1株当たりフリーキャッシュフロー	--	--	--	--	--	--
粗利益	41.74%	27.93%	52.18%	41.59%	46.6%	45.67%
営業利益率	18.32%	1.88%	30.76%	18.41%	25.46%	25.39%
利益率	15.78%	3.35%	25.19%	17.74%	20.78%	20.72%
フリーキャッシュフロー利益率	6.47%	10.27%	3.59%	4.57%	14.31%	4.4%
EBITDA	3,070	444	2,624	1,522	2,132	1,997
EBITDAマージン	23.23%	7.8%	34.9%	23.12%	29.71%	29.22%
D&A による EBITDA	649	337	311	310	305	262
営業利益	2,421	107	2,313	1,212	1,827	1,735
営業利益率	18.32%	1.88%	30.76%	18.41%	25.46%	25.39%
実効税率	17.64%	-73.14%	21.74%	15.86%	21.56%	18.19%

Breakdown

TTM

12/31/2025

06/30/2025

12/31/2024

06/30/2024

12/31/2023

収入

13,210

5,691

7,518

6,583

7,175

6,833

収益成長率（YoY）

-4%

-14%

-4%

11%

収益のコスト

7,696

4,101

3,594

3,845

3,831

3,711

売上総利益

5,514

1,590

3,923

2,738

3,344

3,121

販売、一般および管理

2,322

1,189

1,133

1,242

1,099

1,019

研究開発

921

422

498

443

446

418

運営費用

3,093

1,483

1,609

1,525

1,517

1,385

その他の非営業収入（費用）

税引前利益

2,527

108

2,419

1,387

1,901

1,731

所得税費

446

-79

526

220

410

315

純利益

2,085

191

1,894

1,168

1,491

1,416

純利益成長率

-22%

-84%

27%

-18%

16%

49%

流通済み株式数（希薄化後）

1,953.28

1,816.93

1,816.6

1,817.02

株式変動（前年比）

EPS（希薄化）

1.06

0.09

1.04

0.64

0.82

0.77

EPS成長率

-28%

-85%

27%

-18%

16%

49%

フリーキャッシュフロー

855

585

270

301

1,027

301

1株当たりフリーキャッシュフロー

粗利益

41.74%

27.93%

52.18%

41.59%

46.6%

45.67%

営業利益率

18.32%

1.88%

30.76%

18.41%

25.46%

25.39%

利益率

15.78%

3.35%

25.19%

17.74%

20.78%

20.72%

フリーキャッシュフロー利益率

6.47%

10.27%

3.59%

4.57%

14.31%

4.4%

EBITDA

3,070

444

2,624

1,522

2,132

1,997

EBITDAマージン

23.23%

7.8%

34.9%

23.12%

29.71%

29.22%

D&A による EBITDA

649

337

311

310

305

262

営業利益

2,421

107

2,313

1,212

1,827

1,735

営業利益率

18.32%

1.88%

30.76%

18.41%

25.46%

25.39%

実効税率

17.64%

-73.14%

21.74%

15.86%

21.56%

18.19%

Follow-Up Questions

Báo cáo tài chính chính của The United Laboratories International Holdings Limited là gì?



Theo báo cáo tài chính mới nhất (Form-10K), The United Laboratories International Holdings Limited có tổng tài sản là $0, lợi nhuận ròng 損失 là $0

Tỷ lệ tài chính chính của ULIHF là gì?



Tỷ lệ thanh khoản của The United Laboratories International Holdings Limited là 0, tỷ suất lợi nhuận ròng là 0, doanh thu trên mỗi cổ phiếu là $0.

Doanh thu của The United Laboratories International Holdings Limited được phân bổ theo phân khúc hoặc khu vực địa lý như thế nào?



The United Laboratories International Holdings Limited の最大収益セグメントは Bulk Medicine で、最新の利益発表における収益は 6,909,415,147 です。地域別に見ると、China, including Hong Kong が The United Laboratories International Holdings Limited の主要市場であり、収益は 12,051,782,799 です。

The United Laboratories International Holdings Limited có lợi nhuận không?



いいえ, theo báo cáo tài chính mới nhất, The United Laboratories International Holdings Limited có lợi nhuận ròng 損失 là $0

The United Laboratories International Holdings Limited có nợ không?



いいえ, The United Laboratories International Holdings Limited có nợ là 0

The United Laboratories International Holdings Limited có bao nhiêu cổ phiếu đang lưu hành?



The United Laboratories International Holdings Limited có tổng cộng 0 cổ phiếu đang lưu hành

The United Laboratories International Holdings Limited (ULIHF) 財務

ULIHF 株価推移チャート

主要データ

前終値

始値

当日レンジ

52週レンジ

取引高

平均取引高

配当利回り

1株当たり利益(TTM)

時価総額

UNITED LABORATORIES INTL HLDGS とは何ですか？

The United Laboratories International Holdings Limited (ULIHF) 財務

ULIHF 株価推移チャート

主要データ

前終値

始値

当日レンジ

52週レンジ

取引高

平均取引高

配当利回り

1株当たり利益(TTM)

時価総額

UNITED LABORATORIES INTL HLDGS とは何ですか？

ULIHF 収入

Follow-Up Questions

Báo cáo tài chính chính của The United Laboratories International Holdings Limited là gì?

Tỷ lệ tài chính chính của ULIHF là gì?

Doanh thu của The United Laboratories International Holdings Limited được phân bổ theo phân khúc hoặc khu vực địa lý như thế nào?

The United Laboratories International Holdings Limited có lợi nhuận không?

The United Laboratories International Holdings Limited có nợ không?

The United Laboratories International Holdings Limited có bao nhiêu cổ phiếu đang lưu hành?